This title has ceased 2016.
Biomatter is published as a fully open access, online-only journal! This allows authors free access to and distribution of published articles
Scope of Biomatter: Recent developments in medicine have resulted in a considerable and unprecedented increase in life span. The invention of artificial implants made from biomaterials, in the 1960s, created a whole new scientific field and resulted in revolutionary technologies that strongly contributed to this increase in life expectancy. Since then, many exciting advancements shaped the modern biomaterials science, which itself originated several new fields, with biology playing a major role and where the separation between engineering and health sciences can hardly be distinguishable. Current and future research efforts in this field are believed to result in new therapeutic approaches to prevent and treat debilitating and life-threatening diseases.
Biomatter covers all types of synthetic and natural biomaterials (metals, ceramics, polymers and composites) used for biomedical applications.
About Biomatter: Biomatter appears as a forum to discuss and disclose the relevant advancements in the exciting and fast growing field of science and application of biomaterials. It is widely anticipated that current and future developments will soon result in products with potential to dramatically change the way in which we live, probably even with yet unimaginable future implications in healthcare.
Biomatter is an international and transdisciplinary journal for publication of peer-reviewed original research exploring the clinical and laboratory investigations in the field of science and application of biomaterials, including their physico-chemical and biological properties, as well as clinical performance, and especially those emphasizing the correlation between biomaterials structure and biological performance. The journal intends to cover all applications of biomaterials, including implantable medical devices, drug delivery systems, nanomedicine, tissue engineering and regenerative medicine.
Biomatter is intended to help researchers, academics, clinicians, industry professionals and policy makers, working in related fields of science, engineering and health sciences, to disseminate information associated to biomaterials and its related fields.
Contents and Topics: Biomatter publishes original articles, review articles, short communications and letters to the Editor. Biomatter covers, but is not limited to, the following topics in the context of biomaterials science:
- Advanced materials
- Animal Models
- Antimicrobial strategies
- Artificial cells, tissues and organs
- Biocompatibility studies
- Biodegradable materials
- Bioethics
- Biological response
- Biomaterials synthesis and characterization
- Biomimetic strategies
- Bioreactors
- Biosensors and screening devices
- Blood substitutes
- Cell engineering
- Cell, tissue and organ transplantation
- Clinical Trials
- Drug delivery systems
- Experimental methodologies
- Fluid dynamics, modeling and simulation
- Gene therapy
- In vitro and in vivo approaches
- Interactions between materials and cells and proteins
- Medical devices
- Nanomedicine and nanotechnology
- Regenerative medicine
- Regulatory and ethical issues
- Repair, replacement and Regeneration
- Self-Assembly
- Smart multifunctional intelligent systems
- Stem cell biology
- Structure-property-function relationship
- Surfaces, interfaces and functionalization
- Tissue engineering
Biomatter is an Open Access journal, all accepted manuscripts will be freely available online immediately upon publication. All authors must sign one of the Open Access License Agreements.
| Open Access License | Type of Paper | Fee |
| CC-BY-NC license | Report Short Report Review Commentary | $1000 $750 $750 $500 |
| CC-BY license | Report Short Report Review Commentary | $2000 $1500 $1500 $1000 |
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})